BioXcel Therapeutics (BTAI) PT Lowered to $5 at Canaccord Genuity
Tweet Send to a Friend
(Updated - January 6, 2025 6:58 AM EST)
Canaccord Genuity analyst Sumant Kulkarni lowered the price target on BioXcel ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Sumant Kulkarni lowered the price target on BioXcel ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


